Stay updated on ARCHES-2 Study: ARO-ANG3 Clinical Trial

Sign up to get notified when there's something new on the ARCHES-2 Study: ARO-ANG3 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARCHES-2 Study: ARO-ANG3 Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the site metadata.
    Difference
    0.0%
    Check dated 2026-03-18T20:25:45.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the site.
    Difference
    0.0%
    Check dated 2026-03-11T18:04:19.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    The page shows a new site revision note: Revision: v3.4.2 was added, with v3.4.1 retained for context. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T05:51:33.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and NIH Clinical Center status with a link to opm.gov for updates. Updated the site revision to v3.4.1, replacing the previous v3.4.0.
    Difference
    0.3%
    Check dated 2026-02-04T04:40:48.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Glossary is now shown by default, and QA metadata such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted' are displayed with a new 'Revision: v3.4.0' banner. The No FEAR Act Data label was added and the previous 'No FEAR Act data' label and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T03:09:29.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added to the page and Revision: v3.3.3 was removed. This appears to be a minor metadata update that does not modify the study details, endpoints, or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-01-14T01:21:05.000Z thumbnail image

Stay in the know with updates to ARCHES-2 Study: ARO-ANG3 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARCHES-2 Study: ARO-ANG3 Clinical Trial page.